Back to top

CorVel Corp (NASDAQ:CRVL) Is a Quality Stock with a Debt-Free Balance Sheet and 77% ROIC

Providing workers' compensation and insurance claims management may not sound like a high-growth industry, but one firm has quietly built an operation that any quality investor would want to examine. Quality investing centers on finding businesses with sustainable competitive advantages, consistent growth, and strong financial discipline—companies you could theoretically hold for decades. A stock screener designed to isolate such characteristics recently flagged CorVel Corp (NASDAQ:CRVL), and the numbers help explain why.

CORVEL CORP stock chart

CorVel provides a range of risk management services, including claims administration, bill review, case management, and pharmacy services, primarily for workers’ compensation and auto liability. It packages these either as a fully integrated claims program or as standalone services. The company operates with a low profile but has delivered consistently strong financial results that align with the core principles of quality investing.

Meeting the Criteria for a Quality Holding

The screen applied to CorVel uses a several-filter approach designed to check for consistent growth, strong profitability, financial health, and profit quality. The idea behind each filter is to look for traits that support a long-term buy-and-hold thesis. The screen found that CorVel meets nearly all of them.

Return on Invested Capital (ROIC) at 77%

The most important filter for a quality investor is ROIC, which measures how efficiently management is deploying capital into profitable operations. The screen requires a minimum ROIC of 15%, but CorVel reported an ROIC (excluding cash, goodwill, and intangibles) of 77%. This far exceeds most peers and signals that each dollar reinvested in the business yields an exceptionally high return.

EBIT Growth Outpacing Revenue Growth

A quality company does not just grow; it grows better. The screen demands that EBIT growth exceeds revenue growth over five years, as this indicates improving margins, pricing power, or economies of scale. CorVel’s EBIT compounded at 19.3% annually over the past five years, while revenue growth was also solid. This spread is a classic sign of a firm that is becoming more efficient and profitable as it scales.

Debt-Free Balance Sheet

The screen limits debt to less than five times free cash flow. CorVel has zero debt on its balance sheet. This effectively eliminates financial risk and gives the company significant flexibility to invest in growth, pursue acquisitions, or return capital to shareholders. For a buy-and-hold investor, a debt-free capital structure greatly reduces downside risk during economic downturns.

Profit Quality Above 85%

Profit quality measures how much net income is converted into actual free cash flow. The threshold is 75%, and CorVel posted a five-year average profit quality of 85.7%. This means the company’s reported earnings are backed by real cash generation, not accounting adjustments or non-cash charges. High profit quality provides reassurance that the company’s underlying operations are healthy and self-funding.

A High-Level Look at the Fundamentals

The fundamental analysis report gives CorVel a rating of 6 out of 10, based on a comparison with 102 peers in the health care providers and services industry. The report highlights that the company scores exceptionally well in profitability and financial health. Its return on assets (17.16%), return on equity (27.99%), and profit margin (11.51%) all rank among the top deciles of the industry. The Altman-Z score of 12.48 indicates virtually no bankruptcy risk.

On the growth side, earnings per share have grown at a compound rate of 20.25% per year, and revenue has compounded at 11.64% annually. The one area of caution is valuation: the P/E ratio of 29 is above the S&P 500 average, and the stock is considered expensive on an absolute basis. However, the report also notes the outstanding profitability may justify a higher multiple, and within the industry it actually trades at a cheaper valuation than over 60% of peers.

Valuation and the Quality Trade-Off

Quality investors are not bargain hunters, but they do care about paying a fair price. CorVel’s current valuation reflects its strong fundamentals and historical growth. The P/E ratio is elevated relative to the broad market, but it remains reasonable when set against the company's return on capital and earnings growth trajectory. The enterprise value-to-EBITDA ratio also suggests the stock is not overly expensive compared to industry peers.

Risks and Considerations

No stock is without risk. The fundamental report notes that analyst estimates for future revenue and EPS are unavailable, making it harder to assess forward growth expectations. Additionally, the company does not pay a dividend, which may be a downside for income-focused investors. Still, for a quality investor focused on total return through reinvestment and capital appreciation, these points do not necessarily disqualify it.

For quality investors, a company that combines a debt-free balance sheet, industry-leading profitability, and double-digit earnings growth is rare. CorVel fits that profile.

If you are looking for more stocks that may qualify for a quality investing approach, you can access a regularly updated stock screener that applies the same criteria used in this analysis.

This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own research and consider your financial situation before making any investment decisions.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: